StockDuty ← Dashboard Oct 16, 2026 01:45 PM ET
CatalystCorporate

Revelation Biosciences announces 1-for-7 reverse stock split

1-for-7 reverse stock split signals potential delisting risk and share consolidation.

What happened: Revelation Biosciences (REVB) announced a 1-for-7 reverse stock split, effective Oct. 20, with shares trading on a post-split basis from the start of trading that day. Key numbers: 1-for-7 reverse split; effective Oct. 20. Why it matters: The company said the reverse split is aimed at raising the per-share price. The supplied content does not state further details on the rationale or any analyst or market reaction. Coverage: 3 outlets in 24h
Revelation Biosciences (REVB) announced a 1-for-7 reverse stock split, effective Oct. 20, with shares trading on a post-split basis from the start of trading that day.
The company said the reverse split is aimed at raising the per-share price. The supplied content does not state further details on the rationale or any analyst or market reaction.
Sources